Enjoy complimentary customisation on priority with our Enterprise License!
According to the ulcerative colitis market analysis, Technavio’s research analysts predict that this market will grow steadily at a CAGR of approximately 7% during the forecast period. The increase in patient assistance programs is a major driver of the market. The provision of these programs by vendors will increase the preference for branded drugs because the out-of-pocket charges would be less as the drugs are obtained at lower costs. The increase in the prevalence of ulcerative colitis is another factor, which is expected to boost ulcerative colitis market growth during the forecast period. According to CDC, the worldwide incidence of ulcerative colitis is between 0.5 to 24.5 cases per 100,000 persons per year. The recurrence of the disease’s symptoms is also high. According to Crohn's and colitis foundation of America, about 30% of the people on remission are expected to suffer from the disease flare-up in the future following the treatment and remission.
In terms of molecule type, the biologics segment dominated the ulcerative colitis market in 2015. The better efficacy and safety of these drugs along with increased uptake, especially in developed markets such as the US and Europe, fuel the growth of this segment.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation by molecule type
PART 09: Market segmentation by dosage form
PART 10: Market segmentation by route of administration
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Appendix
PART 19: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.